£86 million funding announced for new medicine and technology

The government has announced new funding of up to £86 million for UK firms to develop medical breakthroughs.

The package will allow small and medium sized enterprises (SMEs) to develop and test new technologies in the NHS. This could include innovations such as digital technologies to help patients manage their conditions from home instead of a hospital, or to develop new medicines.

Access to this funding will also speed up the time it takes to get new technologies from the lab to patients in the NHS.

The announcement is the first step in taking forward the Accelerated Access Review (AAR) – an independently chaired review, which made recommendations to government on speeding up patient access to new technologies.

Technologies that have previously received support are already bringing benefits to patients. For example, MyCOPD is an online system that helps people with chronic obstructive pulmonary disease (COPD) better manage their condition. It has helped over 32,000 patients by helping them improve their breathing, manage flare-ups and track medicine use. This reduces reliance on GP and hospital appointments.

Health Minister Lord O’Shaughnessy said:

“The government’s ambition is that NHS patients get world-leading, life-changing treatments as fast as possible.

“That can’t happen unless we support medical innovation and tear down the barriers – like speed to market and access to funding – that can get in the way, especially for SMEs.

“Our investment in innovation shows how much we value the UK life sciences sector.”

The funding is split into 4 packages. These include:
•£39 million of funding to the Academic Health Science Networks (ASHNs), enabling them to assess the benefits of new technologies and support NHS uptake of those that deliver real benefits to patients according to the local need
•£35 million Digital Health Technology Catalyst for innovators – this will match-fund the development of digital technologies for use by patients and the NHS
•up to £6 million over the next 3 years to help SMEs with innovative medicines and devices get the evidence they need by testing in the real world, building on existing opportunities such as the Early Access to Medicine Scheme (EAMS)
•£6 million Pathway Transformation Fund, which will help NHS organisations integrate new technologies into everyday practices – this will help overcome more practical obstacles such as training staff on how to use new equipment

 

To find out more, please click here 

Featured News

Event: NHS Productivity Congress

Date: 2nd October 2018 Location: ETC Venues, Piccadilly Gardens, Manchester, M1 3HU On 2nd October 2018, Convenzis Events will...

Read more

ABHI Medtech Mission to Texas

Dr Richard Deed, TRUTECH Technology Director and Associate Director for Industry at Health Innovation Manchester, joined an ABHI (Association of...

Read more

Funding for digital technologies

The National Institute of Health Research (NIHR) has announced a new funding call to support digital technologies that aim...

Read more

Cough Monitor innovation generates income for NHS Trust

Chronic coughing (a cough lasting more than 8 weeks) is an unpleasant and distressing condition which can severely impact...

Read more

New online tool seeks to raise awareness of invisible obesity epidemic

With research suggesting that parents are often unable to identify obesity in their own children, a new tool called...

Read more

Free SAGE & THYME Foundation Level workshop

Free SAGE & THYME Foundation Level workshop places celebrating 70 years of the NHS Manchester University NHS Foundation Trust is...

Read more

Subscribe for Updates

Register to receive newsletters and information about new programmes and events.